论文部分内容阅读
目的观察与对比米索前列醇与催产素预防产后出血的的临床疗效情况。方法 120例产妇作为临床研究对象,采取随机数字表法分为米索前列醇组与催产素组,每组60例,观察两组产妇产后出血情况。结果米索前列醇组较催产素组相比,第三产程时间明显缩短,产后2 h出血量明显减少,差异具有统计学意义(P<0.05)。米索前列醇组中有8例产妇出现了寒颤,其中3例产妇出现寒颤后发热,10例产妇出现恶心伴有呕吐感。结论米索前列醇较催产素相比,应用于预防产后出血中的临床效果更加突出,值得推广。
Objective To observe and compare the clinical efficacy of misoprostol and oxytocin in preventing postpartum hemorrhage. Methods A total of 120 maternal women were divided into misoprostol group and oxytocin group by random number table method, with 60 cases in each group. The postpartum hemorrhage was observed in two groups. Results Compared with oxytocin group, the time of the third stage of labor in the misoprostol group was significantly shortened, and the amount of bleeding was significantly reduced 2 h after delivery. The difference was statistically significant (P <0.05). In the misoprostol group, 8 maternal chills occurred, of which 3 maternal fever after chills and 10 maternal nausea with vomiting. Conclusion Compared with oxytocin, misoprostol is more effective in preventing postpartum hemorrhage. It is worth popularizing.